Previous 10 | Next 10 |
The FDA has placed a partial clinical hold on Inovio Pharmaceuticals' (INO) Phase 2/3 clinical trial of COVID-19 vaccine candidate INO-4800 and the Cellectra 2000 delivery device.The agency cites the need to address additional questions about the study. The company says it plans to submit its...
INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800 PR Newswire PLYMOUTH MEETING, Pa., Sept. 28, 2020 PLYMOUTH MEETING, Pa. , Sept. 28, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology com...
Investors who owned Inovio Pharmaceuticals (NASDAQ: INO) and held the stock through the year have been well rewarded for taking a position in the high-risk, high-reward biotech. A $1,000 investment in Inovio at the beginning of January is currently worth $5,133, over a 400% incr...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadA relatively light earnings and conference calendar in the week ahead doesn't mean a break for investors. The U.S. airlin...
Illumina's (ILMN) $8B takeout of liquid biopsy developer GRAIL, which it formed in 2016 with funding assistance from the likes of Bill Gates and Jeff Bezos, may be a watershed event for its use in cancer detection and management.It is developing a multi-cancer early detection test called Gall...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Dr. Anthony Fauci took to Facebook Live on Thursday to assuage increasing concerns about a politicized approval process for a potential coronavirus vaccine."People are always saying, 'How do I know it’s safe? How do I know it's effective? There's a lot of confusion because there are mi...
Reports on Tuesday suggested the FDA was considering stricter guidelines for emergency-use authorization of a coronavirus vaccine, though the White House may not approve of them."It sounds like a political move," President Trump said at a press conference. "When you have Pfizer (PFE), Johnson...
Inovio Pharmaceuticals, Inc. (INO) Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sept 23, 2020, 10:50 AM ET Company Participants Joseph Kim - President & CEO Conference Call Participants Presentation Unidentified Analyst Great, thank you, really appreciate that. Hey, ever...
Shares of Inovio Pharmaceuticals (NASDAQ: INO) are down by 6.2% as of 10:43 a.m. EDT, despite the company not reporting any news. We can probably attribute these losses to a Tweet from Citron Research, which is run by short-seller Andrew Left. In the Tweet, Citron Research claim...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
Elimination of restrictive borrowing facility provides for more efficient debt capacity and cash management Inseego Corp. (Nasdaq: INSG) (the “Company”), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, an...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) fell 0.7% to $0.177 on volume of 56,661,669 shares INVO BioScience Inc. (INVO) rose 233.6% to $2.535 on volume of 49,222,014 shares WiSA Technologies Inc. (WISA) rose 51.8% to $9.26 on volume of 27,894,316 sh...